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2A ABSTRACTS 
Tim A F&hell, M.D., FACC, Kurf , M.D., Themes McDonald, 
Cardioboy Divisbn, Stanford UnMrsity, Stantord, CA 
In order 10 determine whether woconslrfolbn (VC) distal to the site 
of suocessful percutaneous Wansluminal coronary angiophsty (FTCA) is 
there~unof~eredautMegulaSioninahypoperhrsedepicardialw~,nary 
arleyweexamlnedtheasso&&nd thisdMalWC withlasionseverityprkr 
to PTCA in twerQ patients who u n! wwesaful single-vessel PTCA. 
Lesbn severity was claWied as moderate (N=7). were (N=6) or or&al 
(Nm7) (minimal lesion diameters of ~1.0 mm, OS-l.0 mm, and <OS mm, 
respedively) as delefmined by quentitative cotmary arier@rephy (orlho- 
gonel projectbns). MefloQrephy wes pertombed 3,lS and 30 minutes after 
PTCA end then 3 min. after 300 lug of in!wronary n&glycerin (Ic NTG) . 
Quantlletive measuremftnts were mede at each time in amery mments 
distal 10 the clIkWd leskm (Distal), and In B vessel not mmipul~2ed by the 
balloon catheter or mMewire (Conlrol). 
P + 01 eoronuy VCin theDistal 
?I 
minu!esaiaerPTCA corra- 
4 iatedtihlesionsaverfhr, with 14k2%. 
&&I%, and 416% vaskonslrictbn (vs. 
C NTG) in the moderate, severe and criti- 
the site of successful PTCA correlates directly with lesion severity. 
2) These observations suaesl that human epicardial coronary arteries 
‘reset’ thcit autoregulatory responsiveness in the sening of chronic 
hypoperfusion such that restoratbn of more ‘normar perfusbn pressure 
after swwssful PTCA may provoke reflex vawconsfrldion. 
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CARDIAC AND BRAIN LTYPE CALCIUM CHANNELS 
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al Hospital, Boston, h4A 02114 
We. have utilized the sequences of the highly conserved S4 
regtons of voltage-sensmve ion channels to design 
oligonuclcotide 
We have am li 
rimers for the polymerase cham reaction. 
cDNA en CKJ 
P led and cloned a specific fragment of the 
ing Ltypc calcium channels from the heart, 
brain, and skeletal muscle. 
Tbe nucleotide sequences of the cardiac and brain calcium 
channels we obtained are identical over this region, and 
share 78% homology with the skeletal muscle calcium 
channel. Over most of this region, thepredicted amino acid 
sequence of our cardiac and brain calclum channels is 
identical 10 that reported elsewhere for the cardiac calcium 
channel. However, a significant portion of the sequence of 
our dones shows divergence, su 
as a mechanism to generate 
esting alternative exon use 
mu P tlple isoforms of calcium 
chanyls. We have studied the tissue-specific expression of 
these reforms by RNA blot hybrid&Ion analysis. We 
conclude that the heart conans at least two isoforms of the 
Ltype calcium channel, and that one of these is common lo 
both brain and heart. 
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extracellular domains dominates the hexameric structure and 
the cleavage site resides in the cytoplasmic domain. 
pentameric acetylcholine receptor. The 
structure between CGJ and LGJ indicates 
similar quaternary 
design of the channel. 
between the CGI peptide aatibodiee a 
divergence in the cytoplssmic domains of’ t 
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Prior studies utilizing fixed dose, commercially 
available recombinant tissue plasminogen activator (r-tPA) 
have observed a lower patency rate in large patients and 
an increased incfdence of bleeding requiring transfusion 
in small pts. Since weight-adjusted dosing may overcome 
these limitations, we evaluated the safety and efficacy of 
a double chaia r-tPA preparation (Prolysis, Burroughs- 
Wellcome Co.) dosed on an MU/kg basjs (1 MU=? million 
International Units). 232 pts-with weights ranging from 
47-141 ks (median=80 ka) were treated within 6 hrs of 
infarctiin. The r-tPA-was administered intraienousiy at a 
dose of 0.4 MU/kg over the first hr followed by a 
maintenance infusion of 0.2 t&l/kg over an additional 3 
hrs. Coronary arteriography was performed 60 and 90 min 
after initiation of r-tPA therapy. infarct vessel patency 
(TIM1 grade 2-3 flow) occurred in 65% of pts by 60 min and 
in 68% by 90 min of therapy. Serious bleeding 
complications occurred in only 19 pts (8.2%). Although 
logistic regression enalysis revealed no association 
between acute patency and body weight (p=.36), serious 
bleeding complications occurred more frequently in pts 
with a lower body weight (p=.O3). Thus, this dosing 
regimen of Burroughs-Wellcome r-t high 
thrombolytic efficacy irrespective of body size. The 
overall incidence of serious hemorrhagic complications was 
low compared to other studies using invasive techniques; 
however, despite weight-adjusted dosing small patients 
remained at increased risk of bleeding. 
